Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as adjuvant in TAP block for propofol TCI
ChiCTR-IPR-17011609Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in cholelithiasis (2 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoints: dose of propofol during surgery, loss of consciousness and 1 more. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR-IPR-17011609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011609.